跳转至内容

很抱歉,目前系统维护中。在此期间,网站下单功能无法使用。给您带来不便,深表歉意。如需其他帮助,请联系客户联络中心:400 620 3333。

Merck
CN
所有图片(1)

主要文件

404322

Sigma-Aldrich

二氯(1,2-二氨基环己烷)铂(II)

别名:

(1,2-二氨基环己烷)氯化铂(II)

登录查看公司和协议定价

选择尺寸

250 MG
CN¥921.57
1 G
CN¥1,260.06
10 G
CN¥9,181.14
20 G
CN¥16,176.93
50 G
CN¥35,946.28
100 G
CN¥62,923.89

CN¥921.57


预计发货时间April 07, 2025详情


获取大包装报价

选择尺寸

变更视图
250 MG
CN¥921.57
1 G
CN¥1,260.06
10 G
CN¥9,181.14
20 G
CN¥16,176.93
50 G
CN¥35,946.28
100 G
CN¥62,923.89

About This Item

线性分子式:
[C6H10(NH2)2]PtCl2
CAS号:
分子量:
380.17
MDL编号:
UNSPSC代码:
12161600
PubChem化学物质编号:
NACRES:
NA.22

CN¥921.57


预计发货时间April 07, 2025详情


获取大包装报价

反应适用性

core: platinum
reagent type: catalyst

mp

280 °C (dec.) (lit.)

SMILES字符串

Cl[Pt]Cl.NC1CCCCC1N

InChI

1S/C6H14N2.2ClH.Pt/c7-5-3-1-2-4-6(5)8;;;/h5-6H,1-4,7-8H2;2*1H;/q;;;+2/p-2

InChI key

PNNCIXRVXCLADM-UHFFFAOYSA-L

比较类似商品

查看完整比较结果

显示差异

1 of 4

此商品
609471488003348465
technique(s)

bio NMR: suitable, protein expression: suitable

technique(s)

bio NMR: suitable

technique(s)

-

technique(s)

-

mass shift

M+1

mass shift

M+1

mass shift

M+1

mass shift

M+1

isotopic purity

≥98 atom % 15N

isotopic purity

92-97.9 atom % 15N

isotopic purity

60-80 atom % 15N

isotopic purity

10 atom % 15N

Quality Level

200

Quality Level

200

Quality Level

200

Quality Level

200

mp

340 °C (subl.) (lit.)

mp

340 °C (subl.) (lit.)

mp

340 °C (subl.) (lit.)

mp

340 °C (subl.) (lit.)

象形图

Health hazardCorrosion

警示用语:

Danger

危险分类

Carc. 2 - Eye Dam. 1 - Lact. - Muta. 2 - Repr. 1B - Resp. Sens. 1B - Skin Sens. 1 - STOT RE 1

储存分类代码

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

Eyeshields, Gloves, type N95 (US)

  • 技术规格说明书

  • 历史批次信息供参考:

    分析证书(COA)

    Lot/Batch Number

    没有发现合适的版本?

    如果您需要特殊版本,可通过批号或批次号查找具体证书。

    已有该产品?

    在文件库中查找您最近购买产品的文档。

    访问文档库

    G R Gibbons et al.
    Cancer research, 49(6), 1402-1407 (1989-03-15)
    Tetrachloro(D,L-trans)1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) is a new platinum analogue which is less nephrotoxic than cisplatin and is effective in some cell lines which have become resistant to cisplatin. Since platinum(IV) compounds are thought to require reduction to their platinum(II) analogues for activity
    H Cabral et al.
    Nature nanotechnology, 6(12), 815-823 (2011-10-25)
    A major goal in cancer research is to develop carriers that can deliver drugs effectively and without side effects. Liposomal and particulate carriers with diameters of ∼100 nm have been widely used to improve the distribution and tumour accumulation of cancer
    Siden Top et al.
    Chembiochem : a European journal of chemical biology, 4(8), 754-761 (2003-08-05)
    The goal of our study was to potentiate the effects of the ((R,R)-trans-1,2-diaminocyclohexane)-platinum(II) fragment [(DACH)Pt], known for its cytotoxic properties, either with tamoxifen (Tam), the most widely used antiestrogen in the treatment of hormone-dependent breast cancers, or with its active
    V Boudný et al.
    Nucleic acids research, 20(2), 267-272 (1992-01-25)
    Modification of DNA and double-stranded deoxyoligonucleotides with antitumour 1,2-diamino-cyclohexanedinitroplatinum(II) (Pt-dach) complexes was investigated with the aid of physico-chemical methods and chemical probes of nucleic acid conformation. The three Pt-dach complexes were used which differed in isomeric forms of the dach
    P F Carfagna et al.
    Cancer chemotherapy and pharmacology, 27(5), 335-341 (1991-01-01)
    Plasma biotransformations of tetrachloro(d,l-trans)1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) were determined in vivo at both therapeutic (3 mg/kg) and toxic (12 mg/kg) doses in Fischer 344 rats. Tetraplatin was rapidly converted to dichloro(d,l-trans)1,2-diaminocyclohexaneplatinum(II) [PtCl2(dach)]. This conversion was complete at the earliest time measured (7.5

    我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

    联系技术服务部门